{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:12:14Z","timestamp":1790914334915,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.vaccine.2006.11.046","type":"journal-article","created":{"date-parts":[[2006,12,6]],"date-time":"2006-12-06T12:11:17Z","timestamp":1165407077000},"page":"1701-1711","source":"Crossref","is-referenced-by-count":19,"title":["Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3\/4A mRNA"],"prefix":"10.1016","volume":"25","author":[{"given":"Hong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne A.","family":"Babiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"van Drunen Littel-van den Hurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2006.11.046_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1089-3261(02)00067-3","article-title":"Development of a hepatitis C virus vaccine","volume":"7","author":"Inchauspe","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2006.11.046_bib2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/01.TP.0000140927.63952.58","article-title":"Hepatitis B and hepatitis C viruses in liver transplantation","volume":"78","author":"Curry","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2006.11.046_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2004-832928","article-title":"Treatment of chronic hepatitis C infection with peginterferons plus ribavirin","volume":"24","author":"Fried","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"9286","key":"10.1016\/j.vaccine.2006.11.046_bib4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.046_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1586\/14760584.1.4.507","article-title":"RNA-transfected dendritic cells","volume":"1","author":"Nair","year":"2002","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.046_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0092-8674(01)00448-2","article-title":"Dendritic cells as vectors for therapy","volume":"106","author":"Banchereau","year":"2001","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.046_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni0104-7","article-title":"Dendritic cells: a journey from laboratory to clinic","volume":"5","author":"Cerundolo","year":"2004","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.11.046_bib8","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1128\/IAI.72.9.5331-5339.2004","article-title":"Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect","volume":"72","author":"Pouniotis","year":"2004","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2006.11.046_bib9","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.4049\/jimmunol.171.12.6875","article-title":"Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys","volume":"171","author":"Brown","year":"2003","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.046_bib10","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.191.10.1661","article-title":"Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo","volume":"191","author":"d\u2019Ostiani","year":"2000","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2006.11.046_bib11","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.4049\/jimmunol.170.6.3171","article-title":"Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens","volume":"170","author":"Berberich","year":"2003","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.046_bib12","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.4049\/jimmunol.172.10.6281","article-title":"Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC","volume":"172","author":"Ramirez-Pineda","year":"2004","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.11.046_bib13","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1128\/JVI.77.9.5464-5474.2003","article-title":"Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein","volume":"77","author":"Nilges","year":"2003","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.046_bib14","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1128\/JVI.72.5.3812-3818.1998","article-title":"Dendritic cells efficiently induce protective antiviral immunity","volume":"72","author":"Ludewig","year":"1998","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.11.046_bib15","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4049\/jimmunol.166.6.3678","article-title":"Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cells","volume":"166","author":"Ludewig","year":"2001","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.046_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20012100","article-title":"Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells","volume":"195","author":"Schuler-Thurner","year":"2002","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.046_bib17","first-page":"842","article-title":"Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration","volume":"61","author":"Yu","year":"2001","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.vaccine.2006.11.046_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00432-003-0462-6","article-title":"Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7","volume":"129","author":"Nonn","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"issue":"23","key":"10.1016\/j.vaccine.2006.11.046_bib19","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/sj.gt.3301326","article-title":"Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes","volume":"7","author":"Strobel","year":"2000","journal-title":"Gene Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.046_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood-2002-04-1273","article-title":"Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA","volume":"101","author":"Milazzo","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.046_bib21","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1128\/JVI.78.5.2572-2580.2004","article-title":"Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses","volume":"78","author":"Worgall","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.11.046_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.0105-2896.2004.00139.x","article-title":"Cancer immunotherapy with mRNA-transfected dendritic cells","volume":"199","author":"Gilboa","year":"2004","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.046_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1046\/j.1365-2249.2003.02286.x","article-title":"Cancer immunotherapy using RNA-loaded dendritic cells","volume":"134","author":"Ponsaerts","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.046_bib24","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1128\/JVI.71.8.6011-6019.1997","article-title":"Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection","volume":"71","author":"Diepolder","year":"1997","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.046_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/jhep.2003.50051","article-title":"Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization","volume":"37","author":"Jiao","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.046_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/jhep.2003.50115","article-title":"Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection","volume":"37","author":"Wertheimer","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.046_bib27","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/JVI.74.5.2293-2304.2000","article-title":"Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines","volume":"74","author":"Wolk","year":"2000","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.046_bib28","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/JVI.69.3.1575-1581.1995","article-title":"Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing","volume":"69","author":"Tanji","year":"1995","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.046_bib29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.gt.3301933","article-title":"Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3\/4A-expressing tumors in vivo","volume":"10","author":"Frelin","year":"2003","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.046_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"issue":"9","key":"10.1016\/j.vaccine.2006.11.046_bib31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.cgt.7700499","article-title":"Efficient genetic modification of murine dendritic cells by electroporation with mRNA","volume":"9","author":"Van Meirvenne","year":"2002","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.046_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2004.02.011","article-title":"Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes","volume":"9","author":"Liao","year":"2004","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.046_bib33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/36.8.3292647","article-title":"Immunocytochemical identification of bovine Langerhans cells by use of a monoclonal antibody directed against class II MHC antigens","volume":"36","author":"Bryan","year":"1988","journal-title":"J Histochem Cytochem"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2006.11.046_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.81423-0","article-title":"Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3","volume":"87","author":"Yu","year":"2006","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.046_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/vim.1996.9.11","article-title":"Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses","volume":"9","author":"Baca-Estrada","year":"1996","journal-title":"Viral Immunol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2006.11.046_bib36","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1099\/vir.0.79821-0","article-title":"Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3","volume":"85","author":"Yu","year":"2004","journal-title":"J Gen Virol"},{"issue":"18","key":"10.1016\/j.vaccine.2006.11.046_bib37","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1128\/JVI.76.18.9002-9010.2002","article-title":"The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides","volume":"76","author":"Ioannou","year":"2002","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.11.046_bib38","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1128\/JVI.73.12.10214-10223.1999","article-title":"Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response","volume":"73","author":"Lewis","year":"1999","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.11.046_bib39","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1073\/pnas.1131929100","article-title":"Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection","volume":"100","author":"Murata","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.046_bib40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/JVI.77.1.382-390.2003","article-title":"DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice","volume":"77","author":"Pancholi","year":"2003","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.11.046_bib41","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.4049\/jimmunol.171.11.5842","article-title":"Dendritic cell-induced activation of adaptive and innate antitumor immunity","volume":"171","author":"van den Broeke","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.11.046_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00262-004-0605-x","article-title":"New developments in dendritic cell-based vaccinations: RNA translated into clinics","volume":"54","author":"Grunebach","year":"2005","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2006.11.046_bib43","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.4049\/jimmunol.170.12.5892","article-title":"Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes","volume":"170","author":"Muller","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.11.046_bib44","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.174.6.3798","article-title":"Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer","volume":"174","author":"Su","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.046_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1074-7613(03)00353-4","article-title":"Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity","volume":"20","author":"Racanelli","year":"2004","journal-title":"Immunity"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.11.046_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0264-410X(02)00460-7","article-title":"Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus","volume":"21","author":"Matsui","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.046_bib47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2249.2005.02919.x","article-title":"Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection","volume":"142","author":"Encke","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.046_bib48","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1182\/blood.V97.10.3171","article-title":"Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection","volume":"97","author":"Auffermann-Gretzinger","year":"2001","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.vaccine.2006.11.046_bib49","doi-asserted-by":"crossref","first-page":"10862","DOI":"10.1128\/JVI.77.20.10862-10871.2003","article-title":"Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses","volume":"77","author":"Sarobe","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.046_bib50","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1128\/JVI.76.10.5062-5070.2002","article-title":"Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins","volume":"76","author":"Sarobe","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.046_bib51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","article-title":"Limited humoral immunity in hepatitis C virus infection","volume":"116","author":"Chen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2006.11.046_bib52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-642-59605-6_14","article-title":"Cell mediated immune response to the hepatitis C virus","volume":"242","author":"Rehermann","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.046_bib53","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/hep.510280332","article-title":"Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C","volume":"28","author":"Lasarte","year":"1998","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.046_bib54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcv.2004.03.006","article-title":"Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus","volume":"30","author":"Gowans","year":"2004","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.046_bib55","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/j.gastro.2005.12.049","article-title":"The dendritic cell: the immune system's adjuvant-a strategy to develop a HCV vaccine?","volume":"130","author":"Larsson","year":"2006","journal-title":"Gastroenterology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T05:35:47Z","timestamp":1587274547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06012278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0264410X06012278"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}